Issues and Case Studies in Clinical Trial Data Sharing image

May 17, 2013
Conferences
2012-2013
Wasserstein Hall, Milstein East, Harvard Law School
1585 Massachusetts Ave., Cambridge, MA
VIDEO: Dr. Steven Nissen, Cleveland Clinic, Pre-conference Interview
VIDEO: Dr. Deborah Zarin, NIH, Pre-conference Interview
VIDEO: Dr. Yaniv Erlich, Whitehead Institute, Pre-conference Interview

Objectives:

  • To convene key global stakeholders on a neutral platform to review evidence from recent case studies in clinical trial data disclosure
  • To discuss key areas of learning and potential solutions for clinical trial data sharing that may inform policy in this important area moving forward
  • To discuss implications of data sharing initiatives for pharmaceutical regulation in the U.S. and other countries

Please see the conference page for further information. A final agenda, featuring keynote speakers Dr. Jeff Drazen (NEJM) and Dr. Albert J. “AJ” Allen (Lilly) as well as regulators from US, EMA, Canada, Japan, Russia and other countries, may be viewed here

Download the final conference report

Co-sponsored by the Multi-Regional Clinical Trial Center at Harvard University and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School

Videos

VIDEO: Dr. Steven Nissen, Cleveland Clinic, Pre-conference Interview
VIDEO: Dr. Deborah Zarin, NIH, Pre-conference Interview
VIDEO: Dr. Yaniv Erlich, Whitehead Institute, Pre-conference Interview

Tags

intellectual property   pharmaceuticals